Factors influencing morbidity and mortality in pancreaticoduodenectomy.
作者信息
Gilsdorf R B, Spanos P
出版信息
Ann Surg. 1973 Mar;177(3):332-7. doi: 10.1097/00000658-197303000-00015.
Abstract
摘要
相似文献
1
Factors influencing morbidity and mortality in pancreaticoduodenectomy.
Ann Surg. 1973 Mar;177(3):332-7. doi: 10.1097/00000658-197303000-00015.
2
3
Pancreaticoduodenal resection. Twenty years' experience.
Arch Surg. 1973 Jun;106(6):813-7. doi: 10.1001/archsurg.1973.01350180047015.
4
Pancreatoduodenectomy for periampullary carcinomas. Appraisal of two-stage procedure.
Arch Surg. 1966 Jun;92(6):825-33. doi: 10.1001/archsurg.1966.01320240013004.
5
Treatment of carcinoma of the pancreas and the ampulla of Vater.
Minn Med. 1967 Feb;50(2):169-76.
6
A modified pancreaticoduodenectomy.
Surg Gynecol Obstet. 1973 Aug;137(2):259-62.
7
[Duodeno-cephalic pancreatectomy in malignant tumors of the periampullar region].
AMB Rev Assoc Med Bras. 1972 May;18(5):169-72.
8
Periampullary carcinoma.
J Surg Oncol. 1973;5(1):71-5. doi: 10.1002/jso.2930050110.
9
10 years' experience treating pancreatic and periampullary cancer.
Am Surg. 1976 Jun;42(6):441-7.
10
[Tumors of Vater's ampulla].
Chirurgia (1951). 1973 Aug;22(8):673-85.
引用本文的文献
1
Conversion to pancreaticogastrostomy for salvage of disrupted pancreaticojejunostomy following pancreaticoduodenectomy.
Ann Surg Treat Res. 2022 Oct;103(4):217-226. doi: 10.4174/astr.2022.103.4.217. Epub 2022 Oct 7.
2
Whipple's pancreaticoduodenectomy at a resource-poor, low-volume center in Trinidad and Tobago.
World J Clin Oncol. 2022 Sep 24;13(9):738-747. doi: 10.5306/wjco.v13.i9.738.
3
Achieving 'Marginal Gains' to Optimise Outcomes in Resectable Pancreatic Cancer.
Cancers (Basel). 2021 Apr 1;13(7):1669. doi: 10.3390/cancers13071669.
4
Study Protocol of the PreFiPS Study: Prevention of Postoperative Pancreatic Fistula by Somatostatin Compared With Octreotide, a Prospective Randomized Controlled Trial.
Front Med (Lausanne). 2021 Jan 15;7:488. doi: 10.3389/fmed.2020.00488. eCollection 2020.
5
Impact of pulmonary embolism on morbidity and mortality in patients undergoing pancreatic surgery.
Langenbecks Arch Surg. 2021 May;406(3):893-902. doi: 10.1007/s00423-020-02009-4. Epub 2020 Oct 9.
6
Role of preoperative biliary stents, bile contamination and antibiotic prophylaxis in surgical site infections after pancreaticoduodenectomy.
BMC Gastroenterol. 2016 Mar 31;16:43. doi: 10.1186/s12876-016-0460-1.
7
Factors affecting survival in patients who underwent pancreaticoduodenectomy for periampullary cancers.
Ulus Cerrahi Derg. 2015 Jun 1;31(2):72-7. doi: 10.5152/UCD.2015.2674. eCollection 2015.
8
Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project.
HPB (Oxford). 2015 Sep;17(9):763-9. doi: 10.1111/hpb.12426. Epub 2015 Jun 8.
9
Pancreatic surgery: evolution and current tailored approach.
Hepatobiliary Surg Nutr. 2014 Oct;3(5):247-58. doi: 10.3978/j.issn.2304-3881.2014.09.06.
10
Utility of drain fluid amylase measurement on the first postoperative day after pancreaticoduodenectomy.
World J Surg. 2012 Apr;36(4):879-83. doi: 10.1007/s00268-012-1460-0.
本文引用的文献
1
RADICAL PANCREATODUODENECTOMY: A 22-YEAR EXPERIENCE WITH THE COMPLICATIONS, MORTALITY RATE, AND SURVIVAL RATE.
Ann Surg. 1964 Oct;160(4):711-22. doi: 10.1097/00000658-196410000-00013.
2
A long-term appraisal of pancreaticoduodenal resection for peri-ampullary carcinoma.
Ann Surg. 1962 May;155(5):653-62. doi: 10.1097/00000658-196205000-00004.
3
Pancreatico-duodenectomy: forty-one consecutive Whipple resections without an operative mortality.
Ann Surg. 1968 Oct;168(4):629-40. doi: 10.1097/00000658-196810000-00010.
4
Carcinoma of the ampulla of Vater and the terminal bile and pancreatic ducts.
Surg Gynecol Obstet. 1970 Dec;131(6):1052-4.
5
The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.
Surg Gynecol Obstet. 1970 Jun;130(6):1049-53.
Zotero 插件